251 Efficacy and safety of iparomlimab and tuvonralimab in previously treated patients with recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase 2 clinical trial (DUBHE-C-206)

作者：Hanmei Lou, Yun Zhou, Dapeng Li, Hongping Zhang, Mingjun Zhang, Lihua Wang, Huijun Cheng, Zi Liu, Wei Duan, Mei Feng, Chao Wang, Shilin Xue, Hui Li, Xiaoyan Kang, Jihong Liu · 发表于：International Journal of Gynecological Cancer · 年份：2024 · DOI：10.1136/ijgc-2024-esgo.8 · 被引用次数：5 · 研究领域：Cancer Immunotherapy and Biomarkers、Colorectal Cancer Treatments and Studies、Lung Cancer Treatments and Mutations